StuartGoldMD

Pediatric Hematology & Oncology • Chapel Hill, NC

Professor, Pediatrics, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Gold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gold's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27599
Phone+1 919-966-4131
Is this information wrong?

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 1985 - 1988
University of ColoradoResidency, Pediatrics, 1981 - 1985
Vanderbilt University School of MedicineClass of 1981

Certifications & Licensure

NC State Medical License 1989 - 2024
CO State Medical License 1984 - 1989
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Start of enrollment: 2010 Oct 04
Active, not recruiting
Phase 1
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 1
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
Completed
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

5 citations
Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.
Stephen A Schworer, Olivia L Francis, Steven M Johnson, Benjamin D Smith, Stuart H. Gold, Andrew B. Smitherman, Eveline Y Wu> ;Journal of Pediatric Hematology/oncology. 2021 May 31
Long-term outcomes of pediatric and young adult patients receiving radiotherapy for nonmalignant vascular anomalies.
Kevin X. Liu, Nayan Lamba, Karen J. Marcus, Eric Sandler, Stuart H. Gold, Judith F. Margolin, Daphne A. Haas-Kogan, Denise M. Adams> ;Pediatric Blood & Cancer. 2021 Mar 23
42 citations
Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16 INK4a and frailty
Andrew B. Smitherman, William A. Wood, Natalia Mitin, Vanessa L. Ayer Miller, Allison M. Deal, Ian J. Davis, Julie Blatt, Stuart H. Gold, Hyman B. Muss> ;Cancer. 2020 Nov 15
68 citations
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes
Jasmine C. Wong, Victoria Bryant, Tamara Lamprecht, Jing Ma, Michael Walsh, Jason R. Schwartz, Maria del pilar Alzamora, Charles G. Mullighan, Mignon L. Loh, Raul C. R...> ;JCI Insight. 2018 Jul 25
Reply to: Vincristine toxicity with coadministration of fluconazole long-term concerns.
Andrew B. Smitherman, Cassidy B. Faircloth, Stuart H. Gold> ;Pediatric Blood & Cancer. 2017 Jul 1
4 citations
Diagnosing and Monitoring Endocrine Dysfunction, Diabetes, and Obesity in a Cohort of Adult Survivors of Childhood Cancer
Victoria Rollins Hudspeth, Stuart H. Gold, David R. Clemmons> ;Endocrine Practice. 2017 Nov 16
11 citations
Vincristine toxicity with co-administration of fluconazole during induction therapy for pediatric acute lymphoblastic leukemia.
Andrew B. Smitherman, Cassidy B. Faircloth, Allison M. Deal, Michael Troy, Stuart H. Gold> ;Pediatric Blood & Cancer. 2017 Oct 1
44 citations
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Com...
Bryce B. Reeve, Molly McFatrich, Laura C. Pinheiro, Meaghann S. Weaver, Lillian Sung, Janice S. Withycombe, Justin N. Baker, Jennifer W. Mack, Mia K. Waldron, Deborah ...> ;Pediatric Blood & Cancer. 2017 Mar 1
57 citations
A mindful self-compassion videoconference intervention for nationally recruited posttreatment young adult cancer survivors: feasibility, acceptability, and psychosocia...
Rebecca A. Campo, Karen Bluth, Sheila Judge Santacroce, Sarah Knapik, Julia Tan, Stuart H. Gold, Kamaira H. Philips, Susan Gaylord, Gary Asher> ;Supportive Care in Cancer. 2017 Jan 19
Neuroblastoma and spinal muscular atrophy.
Julie Blatt, Stuart H. Gold> ;Journal of Pediatric Hematology/oncology. 2015 Mar 1
29 citations
The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.
Bryce B. Reeve, Janice S. Withycombe, Justin N. Baker, Mary C. Hooke, Jessica C. Lyons, Catriona Mowbray, Jichuan Wang, David R. Freyer, Steven Joffe, Lillian Sung, De...> ;Pediatric Blood & Cancer. 2013 Jul 1
2 citations
Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi.
Daniel G. Olson, Margaret L. Gulley, Weihua Tang, Clifford Wokocha, Oren J. Mechanic, Mina C. Hosseinipour, Stuart H. Gold, Nelson Nguluwe, Charles Mwansambo, Carol G....> ;Clinical Lymphoma, Myeloma & Leukemia. 2013 Apr 1
123 citations
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Qian Liu, Haoqian Chen, Teresa Ojode, Xiangxi Gao, Sandra Anaya-O'Brien, Nicholas A Turner, Jean Ulrick, Rosamma DeCastro, Corin Kelly, Adela R. Cardones, Stuart H. Go...> ;Blood. 2012 Jul 5
6 citations
Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
B S Elizabeth Ju, Chris Adigun, Cherie Dunphy, Stuart Gold, Dean S. Morrell> ;Pediatric Dermatology. 2012 Jul 1
19 citations
Barriers to Hospice for Children as Perceived by Hospice Organizations in North Carolina
Ana Milena Sanchez Varela, Allison M. Deal, Laura C. Hanson, Julie Blatt, Stuart H. Gold, Elisabeth P. Dellon> ;The American Journal of Hospice & Palliative Care. 2012 May 1
37 citations
β-Blockers for Infantile Hemangiomas: A Single-Institution Experience
Julie Blatt, Dean S. Morrell, Scott Buck, Carlton J. Zdanski, Stuart H. Gold, Joseph M. Stavas, Cynthia M. Powell, Craig N. Burkhart> ;Clinical Pediatrics. 2011 Apr 27
First use of electromagnetic setup and real-time tracking in a pediatric patient with vaginal rhabdomyosarcoma.
Randall J. Kimple, Katharine E. Wallen, Talisha Person, Raina N. Erwin, Michael A. Helmrath, Stuart H. Gold, David E. Morris> ;Practical Radiation Oncology. 2011 Jan 1
12 citations
FATIGUE AS MARKER OF THROMBOCYTOPENIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
Julie Blatt, Brent W. Weston, Stuart H. Gold> ;Pediatric Hematology and Oncology. 2010 Feb 2
16 citations
Weaver syndrome and neuroblastoma.
Don W. Coulter, Cynthia M. Powell, Stuart H. Gold> ;Journal of Pediatric Hematology/oncology. 2008 Oct 1
8 citations
Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
Sharon M. Castellino, Todd A. Alonzo, Allen Buxton, Stuart H. Gold, Beverly J. Lange, William G. Woods> ;Pediatric Blood & Cancer. 2008 Jan 1
5 citations
Thymoma in the offspring of a patient with Isaacs syndrome
Don W. Coulter, Stuart H. Gold> ;Journal of Pediatric Hematology/oncology. 2007 Nov 1
4 citations
Autologous bone marrow transplantation for children with AML in first remission.
S. Neudorf, Jean E. Sanders, Nathan L. Kobrinsky, Todd A. Alonzo, Allen Buxton, Jonathan D. Buckley, William B. Howells, Stuart H. Gold, Dorothy R. Barnard, J. Deswart...> ;Bone Marrow Transplantation. 2007 Aug 2
1 citations
A clinical report of a patient with two abnormal cell lines: 46,XX,del(21)(q22.1) and 47,XX,+3
Denise I. Quigley, Jeffery Sailus, Kathleen Kaiser-Rogers, Kathleen W. Rao, Muge Gucsavas Calikoglu, Stuart H. Gold, Shawn E. McCandless> ;American Journal of Medical Genetics. Part A. 2005 Jan 1
51 citations
Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance ...
Steven Neudorf, Jean E. Sanders, Nathan L. Kobrinsky, Todd A. Alonzo, Allen Buxton, Stuart H. Gold, Dorothy R. Barnard, Joetta D. Wallace, Dagmar K. Kalousek, Beverly ...> ;Blood. 2004 May 15
110 citations
Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cance...
Alan S. Gamis, William G. Woods, Todd A. Alonzo, Allen Buxton, Beverly J. Lange, Dorothy R. Barnard, Stuart H. Gold, Franklin O. Smith> ;Journal of Clinical Oncology. 2003 Sep 15
Join now to see all